Daron Evans's Net Worth

$542 Thousand

Estimate Recalculated Sep 9, 2024 12:38AM EST

Who is Daron Evans

Daron Evans does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NEPHROS INC, Nile Therapeutics, Inc., and Rezolute, Inc..

SEC CIK

Daron Evans's CIK is 0001411726

Past Insider Trading and Trends

2009 was Daron Evans's most active year for acquiring shares with 9 total transactions. Daron Evans's most active month to acquire stocks was the month of November. 2024 saw Daron Evans paying a total of $152,334.84 for 367,351 shares, this is the most they've acquired in one year.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NEPHROS INC

CEO Specialty Renal Products

Updated Jun 01, 2021

View Quote Details


Form 4/A	-3.81%	-698.00	$2.70	-$1.88K	Jun 01, 2021	17.62K	Tax	—	May 27
Form 4	—	—	$2.70	$6.00K	May 25, 2021	533.75K	Options	—	May 24
Form 4	1.90%	2.50K	$6.65	$16.63K	Mar 12, 2020	533.76K	Purchase	—	Mar 12
Form 4	1.93%	2.50K	$8.44	$21.11K	Mar 05, 2020	531.26K	Purchase	—	Mar 05
Form 4	66.67%	97.08K	—	—	Feb 05, 2020	528.76K	Grant	—	Feb 01
Form 4	24.42%	29.28K	—	—	Dec 18, 2019	431.68K	Grant	—	Dec 16
Form 4	0.84%	1.00K	$8.35	$8.35K	Nov 18, 2019	402.40K	Purchase	—	Nov 18
Form 4	1.71%	2.00K	$6.92	$13.85K	Aug 22, 2019	401.40K	Purchase	—	Aug 22
Form 4	33.33%	36.40K	—	—	Aug 13, 2019	399.40K	Grant	—	Aug 09
Form 4	3.69%	43.17K	$0.60	$25.76K	Jun 14, 2019	3.27M	Purchase	—	Jun 14
Form 4	12.13%	108.30K	—	—	Dec 18, 2018	3.22M	Grant	—	Dec 14
Form 4	—	—	$0.30	$12.00K	May 14, 2018	3.12M	Options	—	May 14
Form 4	75.36%	79.00K	$0.45	$35.55K	Apr 12, 2018	3.12M	Purchase	—	Apr 10
Form 4	28.57%	218.42K	—	—	Feb 22, 2018	3.04M	Grant	—	Feb 01
Form 4	142.66%	1.02M	—	—	Dec 22, 2017	2.82M	Grant	—	Dec 20
Form 4	4.33%	29.58K	$0.24	$7.19K	Sep 06, 2017	1.80M	Purchase	—	Sep 05 - Sep 06
Form 4	3.97%	4.00K	$0.25	$1.00K	Aug 23, 2017	1.77M	Purchase	—	Aug 22
Form 4	11.41%	70.00K	$0.26	$18.20K	Aug 11, 2017	1.77M	Purchase	—	Aug 11
Form 4	3.10%	21.46K	$0.26	$5.58K	Jun 13, 2017	1.70M	Purchase	—	Jun 09 - Jun 12
Form 4	5.18%	30.00K	$0.26	$7.65K	May 19, 2017	1.68M	Purchase	—	May 18 - May 19
Form 4	3.16%	17.76K	—	—	Apr 04, 2017	1.65M	Grant	—	Mar 31
Form 4	—	166.66K	—	—	Mar 21, 2017	1.63M	Purchase	—	Mar 17
Form 4	61.12%	213.07K	—	—	Dec 23, 2016	1.46M	Grant	—	Dec 23
Form 4	2.70%	9.16K	—	—	Dec 15, 2016	1.25M	Grant	—	Dec 14
Form 4	1.21%	4.07K	$0.32	$1.30K	Dec 09, 2016	1.24M	Purchase	—	Dec 07
Form 4	3.27%	10.62K	$0.34	$3.61K	Dec 06, 2016	1.24M	Purchase	—	Dec 05
Form 4	14.66%	41.53K	$0.32	$13.29K	Dec 02, 2016	1.22M	Purchase	—	Nov 30 - Dec 01
Form 4	—	60.00K	—	—	Jun 07, 2016	1.18M	Purchase	—	Jun 03
Form 4	17.82%	42.84K	—	—	Dec 18, 2015	1.12M	Grant	—	Dec 17
Form 4	41.59%	70.61K	—	—	Sep 11, 2015	1.08M	Grant	—	Sep 09
Form 4	35.18%	44.17K	$0.57	$25.34K	Aug 31, 2015	1.01M	Purchase	—	Aug 27 - Aug 31
Form 4	69.52%	51.50K	$0.53	$27.37K	Aug 20, 2015	890.05K	Purchase	—	Aug 19 - Aug 20
Form 4	—	764.47K	—	—	Apr 17, 2015	838.55K	Grant	—	Apr 15
Form 4	40.19%	21.24K	$0.60	$12.74K	Dec 22, 2014	74.08K	Acquisition	—	Dec 18
Form 4	447.56%	43.19K	—	—	Nov 07, 2014	52.85K	Grant	—	Nov 06
Form 4	1,033.49%	77.51K	$0.30	$645.30	Mar 27, 2014	85.01K	Acquisition	—	Mar 21 - Mar 26
Form 3	—	—	—	—	Dec 04, 2013	7.50K	—	—	—

Showing 37 results

Nile Therapeutics, Inc.

Chief Financial Officer

Updated Apr 02, 2012

View Quote Details


Form 4	166.32%	21.88K	—	—	Apr 02, 2012	1.09M	Purchase	—	Mar 30
Form 4	—	50.00K	—	—	Apr 19, 2011	1.07M	Grant	—	Apr 18
Form 4	26.86%	18.13K	—	—	Jan 05, 2011	1.02M	Grant	—	Jan 03
Form 4	—	250.00K	—	—	Jul 28, 2010	1.00M	Grant	—	Jul 26
Form 4	—	200.00K	—	—	Jul 12, 2010	753.92K	Grant	—	Jul 08
Form 4	170.00%	42.50K	—	—	Feb 17, 2010	553.92K	Grant	—	Feb 15
Form 4	41.74%	50.00K	—	—	Jan 21, 2010	511.42K	Grant	—	Jan 19
Form 4/A	—	92.29K	—	—	Aug 21, 2009	92.29K	Grant	—	Jan 16
Form 4	77.49%	7.90K	—	—	Jul 09, 2009	418.15K	Purchase	—	Jul 07
Form 4	—	25.00K	—	—	Jun 26, 2009	25.00K	Grant	—	Jun 24
Form 4	130.95%	11.00K	$0.76	$8.37K	Mar 13, 2009	19.80K	Purchase	—	Mar 11 - Mar 13
Form 4	—	49.02K	—	—	Jan 20, 2009	49.02K	Grant	—	Jan 16
Form 4	99.34%	4.19K	$0.98	$3.48K	Dec 12, 2008	8.80K	Purchase	—	Dec 12
Form 4	953.50%	3.81K	$0.68	$2.87K	Dec 12, 2008	4.61K	Purchase	—	Dec 11
Form 4	—	800.00	$4.55	$3.64K	Apr 16, 2008	800.00	Purchase	—	Apr 14
Form 4	—	76.53K	—	—	Mar 05, 2008	76.53K	Grant	—	Mar 04
Form 3	—	—	—	—	Sep 19, 2007	—	—	—	—

Showing 17 results

Rezolute, Inc.

CFO

Updated Jun 14, 2024

View Quote Details


Form 4	—	40.00K	$4.04	$161.57K	Jun 14, 2024	203.35K	Purchase	—	Jun 14
Form 4	0.37%	451.00	$3.50	$1.58K	May 31, 2024	163.35K	Purchase	—	May 29
Form 4	30.00%	3.00K	$3.22	$9.67K	May 28, 2024	162.90K	Purchase	—	May 23 - May 24
Form 4	—	20.00K	$1.69	$33.83K	Mar 19, 2024	159.90K	Purchase	—	Mar 15
Form 4	70.52%	50.00K	$1.93	$96.35K	Mar 08, 2024	139.90K	Purchase	—	Mar 08
Form 4	175.52%	50.90K	$1.35	$66.74K	Feb 20, 2024	89.90K	Purchase	—	Feb 16
Form 4	—	275.00K	—	—	Jan 25, 2024	275.00K	Grant	—	Jan 23
Form 3	—	—	—	—	Jan 25, 2024	39.00K	—	—	—

Showing 8 results